Pexapark provides an energy investment platform that specializes in software and advisory services for post-subsidy renewable energy sales and risk management. The company provides an operating system to facilitate the entire energy trading and sales workflow from price discovery to analytics, execution and monitoring, covering solar and on- and offshore wind in 18 countries. Its platform also helps renewable investors to assist them in selling their energy and address clients transact PPAs and managing energy sales. Additionally, it helps clients to structure power sales, complete power purchase agreement transactions, and monitor their energy risks. Pexapark was founded in 2017 and is headquartered in Schlieren, Zurich, Switzerland.

ImmunOs Therapeutics AG is a clinical-stage biotechnology company focused on discovering and developing next generation and novel human immunomodulatory proteins with a role in both innate and adaptive immunity.Their mission is to develop the next generation of novel therapeutics that will improve the lives of patients with serious disease.

CDR-Life is a Zurich-based biotech company specializing in the development of innovative therapeutic antibody fragments, primarily focused on immuno-oncology and ophthalmology. Located in the Bio-Technopark in Schlieren-Zurich, CDR-Life is dedicated to advancing cutting-edge treatments that address critical medical needs.

GlycoEra is a CustomGlycan platform that unlocks the power of glycan-mediated biology to develop a pipeline of novel biologics.

LimmaTech Biologics AG is a clinical-stage biopharmaceutical company focused on developing innovative therapies. By leveraging cutting-edge technology, it aims to advance treatments that address significant unmet medical needs, driving progress in the biopharmaceutical industry and improving patient outcomes.

InSphero provides 3D microtissues for accurate drug testing. Their organotypic models offer a predictive solution for pharmaceutical research.

Biognosys offers top-notch solutions for protein analysis, catering to researchers' needs. Their services are designed to provide the best support possible for studying proteins, ensuring accurate and reliable results every time.

Rejuveron Life Sciences AG is a biotechnology platform dedicated to enhancing healthy aging and extending lifespan. By investing in innovative ideas and talented individuals, the company develops cutting-edge therapies and technologies aimed at improving the quality of life as people age.

Covagen develops bispecific FynomAbs by fusing its human Fynomer binding proteins to antibodies, resulting in therapeutics with novel modes of action and enhanced efficacy in the treatment of inflammatory diseases and cancer. The ability to fuse Fynomers to multiple sites on an antibody allows Covagen to create FynomAbs with tailored architectures to maximize efficacy. Their goal is to access novel biology for each product candidate. Covagen’s lead FynomAb COVA322 is being developed for the treatment of inflammatory diseases such as rheumatoid arthritis and psoriatic arthritis. In October 2012 Covagen entered into a strategic research collaboration and license agreement with Mitsubishi Tanabe / TRL for the development of bispecific FynomAbs against target pairs selected by Mitsubishi Tanabe / TRL. Covagen was founded in 2007 as a spin-off company from ETH Zurich (Swiss Federal Institute of Technology). A strong syndicate of investors supports Covagen’s drug development programs including Novartis Venture Fund, Edmond de Rothschild Investment Partners, Gimv, Seroba Kernel Life Sciences, Ventech, Ascent Biomedical Venture Management, MP Healthcare Venture Management, and Baxter Ventures.

Pregnolia's system accurately measures cervical tissue stiffness in pregnant and non-pregnant women. This innovative technology provides precise assessments for better prenatal care.

Anjarium is focused on creating a new class of non-viral gene therapies to deliver more predictable, enduring, and inclusionary ways to tackle genetic diseases throughout a patient's lifetime. Combining deep domain expertise in synthetic and natural delivery systems, Anjarium is developing a novel class of bioinspired nanomedicine to address a range of genetic diseases, including those that necessitate very large gene delivery. Anjarium’s versatile platform systematically addresses key deficiencies of viral gene therapies in order to provide benefits to patients that have previously been out of reach.

Classtime is an innovative classroom solution that enhances in-person teaching by providing instant feedback on student understanding. By integrating real-time assessments, it helps educators identify learning gaps and tailor instruction, ensuring every student receives the support they need to succeed.

SalesPlaybook empowers B2B entrepreneurs seeking to enhance their market traction by providing sales acceleration enablement. This approach enables startups to achieve Product-Market Fit and accelerate sales growth efficiently, eliminating the need for costly sales team hires.

Faitron specializes in patented temperature-controlled smart heating devices. With HeatsBox, users can easily warm up their food in minutes, promoting healthy eating habits on-the-go.

ImmunOs Therapeutics AG is a clinical-stage biotechnology company focused on discovering and developing next generation and novel human immunomodulatory proteins with a role in both innate and adaptive immunity.Their mission is to develop the next generation of novel therapeutics that will improve the lives of patients with serious disease.

CDR-Life is a Zurich-based biotech company specializing in the development of innovative therapeutic antibody fragments, primarily focused on immuno-oncology and ophthalmology. Located in the Bio-Technopark in Schlieren-Zurich, CDR-Life is dedicated to advancing cutting-edge treatments that address critical medical needs.

GlycoEra is a CustomGlycan platform that unlocks the power of glycan-mediated biology to develop a pipeline of novel biologics.

TONI Digital offers innovative insurance solutions for individuals and businesses. Simplifying the insurance process, they provide tailored coverage options to meet specific needs. With user-friendly technology and expert guidance, TONI Digital ensures peace of mind for all your insurance needs.

ImmunOs Therapeutics AG is a clinical-stage biotechnology company focused on discovering and developing next generation and novel human immunomodulatory proteins with a role in both innate and adaptive immunity.Their mission is to develop the next generation of novel therapeutics that will improve the lives of patients with serious disease.

Rejuveron Life Sciences AG is a biotechnology platform dedicated to enhancing healthy aging and extending lifespan. By investing in innovative ideas and talented individuals, the company develops cutting-edge therapies and technologies aimed at improving the quality of life as people age.

Anjarium is focused on creating a new class of non-viral gene therapies to deliver more predictable, enduring, and inclusionary ways to tackle genetic diseases throughout a patient's lifetime. Combining deep domain expertise in synthetic and natural delivery systems, Anjarium is developing a novel class of bioinspired nanomedicine to address a range of genetic diseases, including those that necessitate very large gene delivery. Anjarium’s versatile platform systematically addresses key deficiencies of viral gene therapies in order to provide benefits to patients that have previously been out of reach.

LimmaTech Biologics AG is a clinical-stage biopharmaceutical company focused on developing innovative therapies. By leveraging cutting-edge technology, it aims to advance treatments that address significant unmet medical needs, driving progress in the biopharmaceutical industry and improving patient outcomes.

Pexapark provides an energy investment platform that specializes in software and advisory services for post-subsidy renewable energy sales and risk management. The company provides an operating system to facilitate the entire energy trading and sales workflow from price discovery to analytics, execution and monitoring, covering solar and on- and offshore wind in 18 countries. Its platform also helps renewable investors to assist them in selling their energy and address clients transact PPAs and managing energy sales. Additionally, it helps clients to structure power sales, complete power purchase agreement transactions, and monitor their energy risks. Pexapark was founded in 2017 and is headquartered in Schlieren, Zurich, Switzerland.

CDR-Life is a Zurich-based biotech company specializing in the development of innovative therapeutic antibody fragments, primarily focused on immuno-oncology and ophthalmology. Located in the Bio-Technopark in Schlieren-Zurich, CDR-Life is dedicated to advancing cutting-edge treatments that address critical medical needs.

Biognosys offers top-notch solutions for protein analysis, catering to researchers' needs. Their services are designed to provide the best support possible for studying proteins, ensuring accurate and reliable results every time.

Classtime is an innovative classroom solution that enhances in-person teaching by providing instant feedback on student understanding. By integrating real-time assessments, it helps educators identify learning gaps and tailor instruction, ensuring every student receives the support they need to succeed.

Pexapark provides an energy investment platform that specializes in software and advisory services for post-subsidy renewable energy sales and risk management. The company provides an operating system to facilitate the entire energy trading and sales workflow from price discovery to analytics, execution and monitoring, covering solar and on- and offshore wind in 18 countries. Its platform also helps renewable investors to assist them in selling their energy and address clients transact PPAs and managing energy sales. Additionally, it helps clients to structure power sales, complete power purchase agreement transactions, and monitor their energy risks. Pexapark was founded in 2017 and is headquartered in Schlieren, Zurich, Switzerland.

Well is a Swiss-based online medical navigator launched in 2020, helping users efficiently navigate the Swiss healthcare system. Located in Schlieren, Well simplifies the healthcare journey by providing easy access to information and resources.